Steven Paul
2019
In 2019, Steven Paul earned a total compensation of $10.1M as Chief Executive Officer, President and Chairman at Karuna Therapeutics, a 932% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $390,000 |
|---|---|
| Option Awards | $9,157,101 |
| Salary | $495,248 |
| Other | $8,400 |
| Total | $10,050,749 |
Paul received $9.2M in option awards, accounting for 91% of the total pay in 2019.
Paul also received $390K in non-equity incentive plan, $495.2K in salary and $8.4K in other compensation.
Rankings
In 2019, Steven Paul's compensation ranked 745th out of 13,971 executives tracked by ExecPay. In other words, Paul earned more than 94.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 745 out of 13,971 | 95th |
Division Manufacturing | 263 out of 5,701 | 95th |
Major group Chemicals And Allied Products | 70 out of 2,200 | 97th |
Industry group Drugs | 59 out of 1,886 | 97th |
Industry Pharmaceutical Preparations | 48 out of 1,398 | 97th |
Source: SEC filing on April 29, 2020.
Paul's colleagues
We found three more compensation records of executives who worked with Steven Paul at Karuna Therapeutics in 2019.